We believe in the promise of biosimilars to deliver cost savings across healthcare and we have access to every approved biosimilars launched in the United States. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.

To date, there have been 61 approvals and 42 launches* in the U.S. biosimilar market. Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. With increased biosimilar adoption, we can improve medication access and affordability, and better support the patients we serve.

Below you will find the biosimilars available through Cencora.